Pesquisar
Rxsight Inc
RXSTAdicionar à lista de desejos
5.610USD
+0.440+8.51%
Fechamento 07/02, 13:00（ET）Cotações atrasadas em 15 min
232.23MValor de mercado
PerdaP/L TTM
Mais detalhes de Rxsight Inc Empresa
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Informações de Rxsight Inc
Código da empresaRXST
Nome da EmpresaRxsight Inc
Data de listagemJul 30, 2021
CEOKurtz (Ron M)
Número de funcionários498
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 30
Endereço100 Columbia Street
CidadeALISO VIEJO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal92656
Telefone19495217822
Sitehttps://www.rxsight.com/
Código da empresaRXST
Data de listagemJul 30, 2021
CEOKurtz (Ron M)
Executivos da empresa Rxsight Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
497.92K
+0.33%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
79.55K
+15.70%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
39.45K
+2.79%
Mr. J. Andy Corley
Mr. J. Andy Corley
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Ron M. Kurtz, M.D.
Dr. Ron M. Kurtz, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
497.92K
+0.33%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
79.55K
+15.70%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
39.45K
+2.79%
Perguntas frequentes
Quem são os cinco principais acionistas de Rxsight Inc?
Os cinco principais acionistas de Rxsight Inc são: Mr. Eric Weinberg
Quantas instituições possuem ações da Rxsight Inc (RXST)?
Em 2026Q1, 467 instituições possuíam ações da Rxsight Inc, com valor de mercado aproximado de 38.60M, representando 93.24% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -10991579.00.